Bliss GVS Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Bliss GVS Pharma has a total shareholder equity of ₹9.6B and total debt of ₹995.5M, which brings its debt-to-equity ratio to 10.3%. Its total assets and total liabilities are ₹12.0B and ₹2.3B respectively. Bliss GVS Pharma's EBIT is ₹1.0B making its interest coverage ratio 48.7. It has cash and short-term investments of ₹1.6B.
Key information
10.3%
Debt to equity ratio
₹995.53m
Debt
| Interest coverage ratio | 48.7x |
| Cash | ₹1.63b |
| Equity | ₹9.63b |
| Total liabilities | ₹2.34b |
| Total assets | ₹11.97b |
Recent financial health updates
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?
Oct 25
Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly
Jul 21Recent updates
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking
Apr 27Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?
Oct 25Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Oct 07How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?
Sep 19What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?
Sep 04Have Insiders Been Buying Bliss GVS Pharma Limited (NSE:BLISSGVS) Shares?
Aug 17The Bliss GVS Pharma (NSE:BLISSGVS) Share Price Has Gained 43% And Shareholders Are Hoping For More
Aug 04Fewer Investors Than Expected Jumping On Bliss GVS Pharma Limited (NSE:BLISSGVS)
Aug 04Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly
Jul 21Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Jul 06Financial Position Analysis
Short Term Liabilities: BLISSGVS's short term assets (₹7.5B) exceed its short term liabilities (₹1.7B).
Long Term Liabilities: BLISSGVS's short term assets (₹7.5B) exceed its long term liabilities (₹620.5M).
Debt to Equity History and Analysis
Debt Level: BLISSGVS has more cash than its total debt.
Reducing Debt: BLISSGVS's debt to equity ratio has reduced from 12% to 10.3% over the past 5 years.
Debt Coverage: BLISSGVS's debt is well covered by operating cash flow (103%).
Interest Coverage: BLISSGVS's interest payments on its debt are well covered by EBIT (48.7x coverage).